Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22
PubPharm (3.278)
1
A dose escalation trial to assess the safety and tolerability of multiple doses of the CAN04 antibody, in patients with solid malignant tumors. : An open label, dose escalation followed by dose expansion, safety and tolerability trial of CAN04, a fully humanized monoclonal antibody against IL1RAP, in subjects with solid malignant tumors - CANFOUR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Study of ALRN-6924, for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer : A Phase 1b/2 Study of the Dual MDMX/MDM2 Inhibitor, ALRN-6924, for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Long term continuous infusion ch14.18/CHO plus s.c. aldesleukin (IL-2) randomised : A PHASE I/II DOSE SCHEDULE FINDING STUDYFOR CH14.18/CHO CONTINUOUS INFUSION COMBINED WITH SUBCUTANEOUS ALDESLEUKIN (IL-2)IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSING NEUROBLASTOMA - Long term continuous infusion ch14.18/CHO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A study to evaluate the safety, tolerability and efficacy of AUP1602-C product for diabetic foot ulcers : A Phase 1/2A clinical study to evaluate the safety, tolerability and efficacy of single and repeated doses of AUP1602-C as topical treatment of diabetic foot ulcers
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
This trial will evaluate the safety and efficacy of HepaStem compared to placebo in patients with a cirrhotic liver condition called Acute on Chronic Liver Failure (ACLF). The study will be performed in multiple centers and in a double-blinded manner, meaning neither the patients nor the treating physicians know who is on placebo or the study drug. : Randomized, placebo-controlled, double blind, multi-centre Phase IIb study to evaluate the efficacy and safety of HepaStem in patients with Acute on Chronic Liver Failure (ACLF) - DHELIVER - HEP102 - DHELIVER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients with Huntington’s Disease : A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients with Huntington’s Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19 or ALLO-501 : Long-term follow-up study of patients who have previously been exposed to UCART19 / ALLO-501 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma : FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma - FaR-RMS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Study into the safety and activity of the drug Crizotinib for children with malignant tumors : A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies - CRISP
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors : A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[328]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
3.278
Aufsätze
3.278
E-Artikel
3.278
E-Ressourcen
Zeitschriftentitel
3.278
WHO International Clinical Trials Registry Plat...
Thema
3.278
610
Phase: Phase 1
3.278
Recruitment Status: Authorised-recruitment may ...
3.278
Study Type: Interventional
26
Medical Condition: Advanced Solid Tumors MedDRA...
18
Medical Condition: B-cell Non-Hodgkin LymphomaD...
18
Medical Condition: High grade serous ovarian ca...
18
Medical Condition: Metastatic Castration-Resist...
18
Medical Condition: Relapsed or Refractory Multi...
14
Medical Condition: Huntington's Disease MedDRA ...
14
Medical Condition: KRAS p.G12C mutant advanced ...
14
Medical Condition: Melanoma MedDRA version: 21....
14
Medical Condition: Relapsed or Refractory Acute...
14
Medical Condition: The ‘wet’ form of age-re...
14
Medical Condition: pediatric CD22-positive rela...
12
Medical Condition: PMF or PPV- MF, or PET- MF M...
12
Medical Condition: Pediatric patients with Phil...
12
Medical Condition: Primary Myelofibrosis (PMF),...
12
Medical Condition: Relapsed/Refractory Myelofib...
12
Medical Condition: Solid Tumors MedDRA version:...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.510
2020-
768
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.240
Englisch
34
Unbestimmt
4
Italienisch
Haven't found what you're looking for?
Wird geladen...